StocksMedium•14 October 2026•
1 min read
EU Accepts Sanofi Settlement to End Flu Vaccine Antitrust Probe
Key Facts
1The European Commission accepted Sanofi's commitments to address concerns regarding its marketing practices for flu vaccines.
The European Commission accepted Sanofi's commitments to address concerns regarding its marketing practices for flu vaccines. The Wall Street Journal reported that the European Union's executive arm approved these concessions to settle an antitrust investigation into the company's past marketing messages regarding a rival flu shot.
The settlement is intended to remove legal uncertainty and avoid potential heavy fines for the pharmaceutical firm. Amid these regulatory developments, SNYNF closed at $76.76 on October 13, 2026, having reached a session high of $79.45 on that day.